Las guas del American College of Physicians (ACP) priorizan los agonistas del receptor GLP-1 y los inhibidores de SGLT2 sobre las sulfonilureas debido a sus beneficios en resultados importantes para el paciente, aunque las sulfonilureas siguen siendo opciones en ciertos contextos clnicos
While patches are promising, its important to note that GLP-1 patches are still emerging in clinical trials and are not as widely available as injections
Note : Approximately 70% of American adults are overweight or obese
Psychiatry & Internal & Sleep Medicine located in Scottsdale, AZ GLP-1 Weight Loss Treatment Physician-guided GLP-1 therapy is a powerful tool to support weight loss by helping you feel fuller longer, reduce cravings, and improve metabolic health
As a novel triple-receptor agonist peptide, retatrutide activates GLP-1, glucagon, and GIP pathways simultaneously
However, recent research has begun to explore their effects beyond metabolic outcomes